Finance

Beta
Lists
SVA:NASDAQ
Sinovac Biotech Ltd
$6.47
0.00%
(0.00) 1D
Feb 22, 5:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Volume
0.00
52-wk high
$28.18
52-wk low
$22.40
EPS
-$0.83
Shares outstanding
59.32M
No. of employees
3K
Volume
0.00
52-wk high
$28.18
52-wk low
$22.40
EPS
-$0.83
Shares outstanding
59.32M
No. of employees
3K
News stories
From sources across the web
Profile
Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing, that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government. Wikipedia
About Sinovac Biotech Ltd
CEOWeidong Yin
Employees2.6K
Founded2001
Headquarters-
SectorBiotechnology
Websitesinovac.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
65.14M
65.14M
127.87M
127.87M
Cost of goods sold
24.40M
24.40M
37.61M
37.61M
Cost of revenue
24.40M
24.40M
37.61M
37.61M
Research and development expenses
63.46M
63.46M
44.63M
44.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.61M
73.61M
92.88M
92.88M
Operating expense
134.89M
134.89M
139.74M
139.74M
Total operating expenses
159.30M
159.30M
177.35M
177.35M
Operating income
-94.16M
-94.16M
-49.48M
-49.48M
Other non operating income
80.95M
80.95M
-130.35M
-130.35M
EBT including unusual items
-47.89M
-47.89M
-83.16M
-83.16M
EBT excluding unusual items
-12.91M
-12.91M
-16.72M
-16.72M
Income tax expense
390.50K
390.50K
-32.02M
-32.02M
Effective tax rate
-0.82%
-0.82%
38.51%
38.51%
Other operating expenses
-1.77M
-1.77M
-245.50K
-245.50K
Net income
-10.83M
-10.83M
-19.01M
-19.01M
Net profit margin
-16.63%
-16.63%
-14.86%
-14.86%
Earnings per share
-
-
-
-
Interest and investment income
6.47M
6.47M
163.87M
163.87M
Interest expense
-2.05M
-2.05M
-2.86M
-2.86M
Net interest expenses
4.42M
4.42M
161.01M
161.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
-69.88M
-69.88M
-25.04M
-25.04M
Gain or loss from assets sale
26.96M
26.96M
41.66M
41.66M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer